Chargement en cours...
Placebo-controlled pilot study of ramelteon for adiposity and lipids in patients with schizophrenia
OBJECTIVE: Few interventions have been successful to prevent or reverse the medical complications associated with antipsychotic agents in the schizophrenia population. In particular, no single agent can correct multiple metabolic abnormalities such as insulin resistance, hyperlipidemia, inflammation...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3725551/ https://ncbi.nlm.nih.gov/pubmed/21869685 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JCP.0b013e31822bb573 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|